PL3691666T3 - Kompozycja farmaceutyczna zawierająca kombinację probiotyku i prebiotyku do leczenia zahamowania wzrostu - Google Patents

Kompozycja farmaceutyczna zawierająca kombinację probiotyku i prebiotyku do leczenia zahamowania wzrostu

Info

Publication number
PL3691666T3
PL3691666T3 PL18864785.3T PL18864785T PL3691666T3 PL 3691666 T3 PL3691666 T3 PL 3691666T3 PL 18864785 T PL18864785 T PL 18864785T PL 3691666 T3 PL3691666 T3 PL 3691666T3
Authority
PL
Poland
Prior art keywords
stunting
prebiotic
probiotic
treat
combination
Prior art date
Application number
PL18864785.3T
Other languages
English (en)
Inventor
Pravas Ranjan Misra
Original Assignee
Chr. Hansen A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chr. Hansen A/S filed Critical Chr. Hansen A/S
Publication of PL3691666T3 publication Critical patent/PL3691666T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Immunology (AREA)
PL18864785.3T 2017-10-04 2018-10-04 Kompozycja farmaceutyczna zawierająca kombinację probiotyku i prebiotyku do leczenia zahamowania wzrostu PL3691666T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201731035101 2017-10-04
PCT/IB2018/057721 WO2019069267A1 (en) 2017-10-04 2018-10-04 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTICS AND PREBIOTICS TO TREAT GROWTH DELAY IN CHILDREN

Publications (1)

Publication Number Publication Date
PL3691666T3 true PL3691666T3 (pl) 2024-09-02

Family

ID=65994708

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18864785.3T PL3691666T3 (pl) 2017-10-04 2018-10-04 Kompozycja farmaceutyczna zawierająca kombinację probiotyku i prebiotyku do leczenia zahamowania wzrostu

Country Status (9)

Country Link
US (3) US11571449B2 (pl)
EP (2) EP3691666B1 (pl)
KR (3) KR20240142600A (pl)
CN (1) CN111432827A (pl)
BR (1) BR112020006693A2 (pl)
CA (1) CA3078306A1 (pl)
ES (1) ES2982230T3 (pl)
PL (1) PL3691666T3 (pl)
WO (1) WO2019069267A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019069267A1 (en) 2017-10-04 2019-04-11 Asian Institute Of Public Health PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTICS AND PREBIOTICS TO TREAT GROWTH DELAY IN CHILDREN
US20230110977A1 (en) * 2020-02-27 2023-04-13 Abbott Laboratories Methods of improving bone health
CN115039887A (zh) * 2022-08-15 2022-09-13 源民生物科技(山东)有限公司 一种具有增肌护骨功能的益生菌群组合物
IT202300025683A1 (it) * 2023-12-01 2025-06-01 Health Progress Italia S R L Composizione in gel per la somministrazione orale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132710A (en) * 1997-03-17 2000-10-17 Probiotix, Inc. Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
EP2269465A1 (en) * 2006-05-03 2011-01-05 Probiotical S.p.a. Compositions comprising Bifidobacterium adolescentis
ITMI20072260A1 (it) * 2007-12-03 2009-06-04 Anidral Srl Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.
EP2493336A1 (en) * 2009-10-29 2012-09-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
CN103491969A (zh) 2011-02-09 2014-01-01 拉维沃公司 恢复和重建肠道微生物群的合生素组合物
KR102324015B1 (ko) * 2012-09-25 2021-11-10 아퀼론 씨와이엘 에스.엘. 프로바이오틱 및 프리바이오틱 조성물
WO2014178007A2 (en) * 2013-05-02 2014-11-06 Pinaki Panigrahi A pharmaceutical composition comprising a combination of probiotic and prebiotic
RU2699981C2 (ru) * 2014-08-18 2019-09-11 Сосьете Де Продюи Нестле С.А. Пребиотики для снижения риска развития ожирения в дальнейшей жизни
WO2019069266A1 (en) 2017-10-04 2019-04-11 Asian Institute Of Public Health PHARMACEUTICAL COMPOSITION COMPRISING A PROBIOTIC AND PREBIOTIC FOR PREVENTING ACQUISITION OR TREATING OF PHARMACORETISTIVE INFECTIONS
WO2019069267A1 (en) 2017-10-04 2019-04-11 Asian Institute Of Public Health PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTICS AND PREBIOTICS TO TREAT GROWTH DELAY IN CHILDREN

Also Published As

Publication number Publication date
BR112020006693A2 (pt) 2020-10-06
ES2982230T3 (es) 2024-10-15
US20250332206A1 (en) 2025-10-30
CA3078306A1 (en) 2019-04-11
EP3691666A4 (en) 2021-06-23
WO2019069267A1 (en) 2019-04-11
KR102708415B1 (ko) 2024-09-23
US20200246402A1 (en) 2020-08-06
KR20200112803A (ko) 2020-10-05
US20230149484A1 (en) 2023-05-18
EP3691666B1 (en) 2024-04-24
EP3691666C0 (en) 2024-04-24
EP4470625A2 (en) 2024-12-04
KR20250173593A (ko) 2025-12-10
EP3691666A1 (en) 2020-08-12
CN111432827A (zh) 2020-07-17
EP4470625A3 (en) 2025-02-26
KR20240142600A (ko) 2024-09-30
US11571449B2 (en) 2023-02-07

Similar Documents

Publication Publication Date Title
IL251834A0 (en) Pharmaceutical compositions containing peptide variants and methods of using them
PL3375448T3 (pl) Szczep posiadający zdolność do hamowania otyłości i zawierająca go kompozycja farmaceutyczna
PL3487505T3 (pl) Podawanie i dawkowanie diaminofenotiazyn
IL257784A (en) Methods and compositions for reducing fat
IL269901B (en) Pharmaceutical compounds and methods of treating cardiovascular diseases
ZA201906548B (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof
PT3277295T (pt) Composição para o tratamento de um estado metabólico patogénico da flora intestinal e de doenças derivadas
PL3209307T3 (pl) Kompozycje probiotyczne i prebiotyczne
SG10201402819WA (en) Composition for prevention and treatment of joint pain and the method of preparation thereof
IL280690A (en) Pharmaceutical preparations that include DGLA and their use
PL3691666T3 (pl) Kompozycja farmaceutyczna zawierająca kombinację probiotyku i prebiotyku do leczenia zahamowania wzrostu
IL251687B (en) Medicinal composition for use in treatment to prevent vitamin and mineral deficiencies in patients who have undergone gastric bypass surgery
SG11201704430SA (en) Preventive and/or therapeutic agent of immune disease
IL263976B1 (en) Preparations containing memantin and melatonin
PL3691665T3 (pl) Kompozycja farmaceutyczna zawierająca probiotyk i prebiotyk do zapobiegania nabywaniu lub do leczenia zakażeń lekoopornych
PT3503885T (pt) Composição farmacêutica e métodos de utilização
IL271875A (en) Preparations containing totarol and their use
SG11202003886TA (en) Use of serotonergic drugs to treat virus-induced thrombocytopenia
GB201710382D0 (en) Administration and dosage of Diaminophenothiazines
GB201612863D0 (en) Administration and dosage of diaminophenothiazines
GB201805577D0 (en) Prebiotic compositions and methods of production thereof
GB201805578D0 (en) Prebiotic compositions and methods of production thereof